对侧预防性乳房切除并发症是否延迟辅助治疗
回顾性研究纳入241例接受对侧预防性乳房切除加即刻乳房再造并后续辅助治疗的患者,比较同期与延迟手术对并发症及辅助治疗时机的影响。同期组辅助治疗前并发症发生率为16.7%,其中3.2%仅发生在对侧预防性切除侧;仅5.9%延迟辅助治疗,2.2%归因于对侧预防性切除侧。结论认为经仔细选择的患者可安全同期手术。
要点
- 同期对侧预防性乳房切除加即刻再造在辅助治疗前并发症率为16.7%。
- 仅5.9%患者延迟辅助治疗,其中2.2%由对侧预防性切除侧导致。
- 经仔细选择的患者可安全同期行对侧预防性切除与即刻再造。
核心结论
- 经仔细选择的患者可在乳房切除同期安全行对侧预防性乳房切除加即刻乳房再造。
- 研究结果有助于患者在对侧预防性乳房切除时机决策中权衡风险与获益。
研究设计与样本
- 回顾性研究,纳入6年间连续接受对侧预防性乳房切除加即刻乳房再造并接受辅助治疗的患者。
- 共241例患者(482侧乳房),同期组186例(372侧),延迟组55例(110侧)。
主要发现
- 同期组辅助治疗前并发症发生于31例(16.7%),其中6例(3.2%)仅在对侧预防性切除侧。
- 同期组辅助治疗延迟发生于11例(5.9%),其中4例(2.2%)由对侧预防性切除侧导致。
- 延迟组乳腺癌分期(p < 0.001)、肿瘤类别(p = 0.0072)和淋巴结类别(p < 0.001)显著更高。
临床怎么用
- 对侧预防性乳房切除加即刻再造可考虑与乳房切除同期进行,但需仔细选择患者。
- 术前应与患者共享决策,明确同期手术对辅助治疗延迟的潜在风险与获益。
局限性
- 为回顾性研究,证据等级为治疗性III级。
- 延迟组乳腺癌分期、肿瘤类别和淋巴结类别显著更高,组间基线存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is ongoing debate regarding the optimal timing of contralateral prophylactic mastectomy fueled by concern that performing it at the time of the mastectomy for the index breast cancer may delay adjuvant therapy. The study objective was to examine the effect of simultaneous contralateral prophylactic mastectomy with immediate breast reconstruction on the complication rate and adjuvant therapy timing. METHODS: A retrospective study was conducted of consecutive patients who underwent contralateral prophylactic mastectomy with immediate breast reconstruction and received adjuvant therapy over a 6-year period. Demographic, treatment, and outcomes data were collected, and relationships between multiple variables and outcomes were evaluated. RESULTS: Of 241 patients (482 breasts) included, 186 (372 breasts) underwent simultaneous index breast mastectomy and contralateral prophylactic mastectomy with immediate breast reconstruction followed by adjuvant therapy (immediate group), and 55 (110 breasts) underwent index mastectomy, then adjuvant therapy, followed by delayed contralateral prophylactic mastectomy with immediate breast reconstruction (delayed group). Demographics were similar, although breast cancer stage (p < 0.001), tumor category (p = 0.0072), and nodal category (p < 0.001) were significantly higher in the delayed group. In the immediate group, complications before adjuvant therapy occurred in 31 patients (16.7 percent), and in six patients (3.2 percent) complications occurred only in the contralateral prophylactic mastectomy breast; delay to adjuvant therapy occurred in 11 patients (5.9 percent), in four (2.2 percent) of whom the contralateral prophylactic mastectomy breast was responsible for the delay. CONCLUSIONS: Contralateral prophylactic mastectomy with immediate breast reconstruction can be performed safely at the time of the index mastectomy in carefully selected patients. These findings will engage patients seeking contralateral prophylactic mastectomy in shared decision-making regarding optimal timing with respect to the risks and benefits. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Sharabi SE, Baumann DP, Selber JC, et al. Complications of Contralateral Prophylactic Mastectomy: Do They Delay Adjuvant Therapy? Plast Reconstr Surg. 2020. PMID: 33136936. doi:10.1097/PRS.0000000000007237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。